Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Talimogene Laherparepvec
Talimogene Laherparepvec
Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab
Yahoo
Tue, 06/2/15 - 09:15 am
Amgen
Roche
triple negative breast cancer
Talimogene Laherparepvec
atezolizumab
colorectal cancer
FDA Panel Gives Thumbs-Up To Amgen's Virus-Based Melanoma Drug
Forbes
Wed, 04/29/15 - 06:31 pm
FDA
Amgen
melanoma
Talimogene Laherparepvec
T-Vec
FDA review challenges Amgen on a questionable T-Vec study
Fierce Biotech
Mon, 04/27/15 - 09:46 am
FDA
Amgen
T-Vec
Talimogene Laherparepvec
cancer
cancer vaccines
[video]Amgen's Conundrum
Motley Fool
Mon, 04/14/14 - 06:18 pm
Amgen
Talimogene Laherparepvec
Amgen Spiking Lower 1.5%, Says Primary Endpoint of Durable Response Rate Met in Phase 3 Study of Talimogene, Secondary Endpoint Not Met
Yahoo/Benzinga
Fri, 04/4/14 - 09:14 am
Amgen
Talimogene Laherparepvec
melanoma
Amgen's talimogene laherparepvec reduced size of tumors in Phase 3 study
Yahoo/The Fly on the Wall
Sat, 03/15/14 - 10:03 am
Amgen
Talimogene Laherparepvec
melanoma
Data on Amgen's Pipeline Candidates
Yahoo/Zacks.com
Thu, 11/21/13 - 11:05 am
Amgen
evolocumab
PCSK9 inhibitors
cholesterol
Talimogene Laherparepvec
Amgen presents survival data from Phase 3 study of talimogene laherparepvec
Yahoo/Fly on the Wall
Mon, 11/18/13 - 04:39 pm
Amgen
Talimogene Laherparepvec
melanoma
Amgen melanoma drug improved survival by 21 pct in interim look
Reuters
Sat, 06/1/13 - 12:12 pm
Amgen
T-Vec
Talimogene Laherparepvec
melanoma
[video]Will Amgen's Novel Drug Revolutionize Cancer Treatment?
Motley Fool
Mon, 05/20/13 - 05:19 pm
Amgen
Talimogene Laherparepvec
melanoma
Recent Melanoma Trial Data Has Biotech Stocks Moving
Seeking Alpha
Wed, 03/27/13 - 12:31 pm
melanoma
Amgen
TVEC
Talimogene Laherparepvec
ImmunoPulse
OncoSec